We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
178 result(s) found, displaying 101 to 110
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Prescription medicine registrationActive ingredients: abatacept (rch).
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Nivolumab
-
Designation or determinationPriority review
-
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Elotuzumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for POMALYST pomalidomide 4 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for POMALYST pomalidomide 3 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for POMALYST pomalidomide 1 mg capsule blister pack.